TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Idexx Laboratories Norge AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,329
|
1,252
|
1,110 |
| Financial expenses |
1
|
1
|
0 |
| Earnings before taxes |
325
|
248
|
210 |
| Total assets |
3,375
|
2,781
|
2,365 |
| Current assets |
3,287
|
2,749
|
2,322 |
| Current liabilities |
1,819
|
1,402
|
1,092 |
| Equity capital |
1,504
|
1,319
|
1,203 |
| - share capital |
10
|
11
|
11 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
44.6%
|
47.4%
|
50.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
24.5%
|
19.8%
|
18.9% |
| Return on assets (ROA) |
9.7%
|
9.0%
|
8.9% |
| Current ratio |
180.7%
|
196.1%
|
212.6% |
| Return on equity (ROE) |
21.6%
|
18.8%
|
17.5% |
| Change turnover |
140
|
213
|
-8,632 |
| Change turnover % |
12%
|
20%
|
-89% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.